12th World Congress News Center

12th World Congress:"Neuromodulation: Medicine Evolving Through Technology"

News Releases:

 FREE public lecture "Neurostimulation & patients"

Moderator: journalist Bernard Derome
Organized by the Canadian Neuromodulation Society & INS
Saturday, June 6, 2015 from noon - 4:40 p.m.

About the INS World Congress

The INS World Congress draws more than 1,500 clinical, engineering and investment leaders and entrepreneurs from five continents and encompasses the full span of existing and emerging neuromodulation therapies.

When: June 6 - 11, 2015

Where: Fairmont Queen Elizabeth Hotel
900 Rene Levesque Blvd. W
Montreal, Quebec, Canada
H3B 4A5


Media Contact
Please email for interviews or onsite press credentials:

Nancy Garcia
Website and Public Education Manager

ngarcia (at) neuromodulation.com

2000 Van Ness Ave.,#414
San Francisco, CA 94109

Office: +1 415 683 3237

Online Newsroom

12th World Congress Scientific Program (preliminary) 

Daily session topics include bioelectric medicine (electroceuticals), headache and chronic pain, brain interventions for issues such as Alzheimer’s disease, epilepsy, urogenituary and gastrointestinal issues (including obesity and pelvic motility disorders), heart failure, cancer pain, healthcare access and economics, sensing technologies, neuroimaging and functional investigations.

Specialists in attendance include neurologists, urologists, pain doctors, neurosurgeons, cardiovascular surgeons, gastroenterologists, psychiatrists, physical rehabilitation experts, bioengineers, and scientists such as neurophysiologists and neurochemists.

Did You Know?

". . . Newly developed methods . . . have made it possible to develop new, very powerful therapeutic approaches to serious clinical conditions. Every new branch soon produces its own ramifications and neuromodulation looks like a very fast-growing tree.

-    Professor Alim Louis Benabid, MD, PhD, pioneer in developing deep brain stimulation for Parkinson’s disease, Clinatec Institute, LETI-Minatec, CEA Grenoble, Grenoble, France

Neuromodulation improves functioning and reduces suffering through reversible, non-systemic approaches to treatment-resistant conditions that have a neurological basis, such as chronic neuropathic pain or medically refractory epilepsy.

While the devices have received regulatory approval from every major health economy, growing knowledge in neuroscience, microfabrication and translational medicine has led to rapid development of new refinements and emerging indications.

In use for more than 40 years, neuromodulation therapies harness the body's own neural circuitry and deliver a stimulus to discrete locations in the nervous system, often through small implanted electrical-stimulation or drug-delivery devices. Neuromodulation therapies build upon technologies for cochlear implants and cardiac pacemakers, and include spinal cord stimulation for persistent pain, deep brain stimulation for movement disorder, or sacral neurostimulation for bladder or bowel disorders.



Last Updated on Monday, November 22, 2021 02:17 PM